BackgroundCheck.run
Search For

Michael Lo, 57323 W 83Rd St APT 3C, New York, NY 10024

Related to:
Ann E Coleman 97 Michael Poon 64 William Miller

Michael Lo Phones & Addresses

323 W 83Rd St APT 3C, New York, NY 10024   

6560 Wetherole St, Rego Park, NY 11374    718-4597469   

6560 Wetherole St APT 6K, Rego Park, NY 11374    718-4597469   

Elmhurst, NY   

Get Report
Control this profile

Mentions for Michael Lo

Career records & work history

License Records

Michael R Lo Biondo

Licenses:
License #: 1683 - Expired
Category: Nursing Home Administrator
Issued Date: Jan 1, 1972

Michael Lo resumes & CV records

Resumes

Michael Lo Photo 43

Michael Lo - New York, NY

Work:
JPMorgan Chase & Co - Jersey City, NJ Jul 2010 to Jul 2013
Associate Business Analyst Microsoft - Redmond, WA May 2009 to Aug 2009
Program Manager Intern EcVision - Hong Kong, Hong Kong Island Jun 2008 to Aug 2008
Software Engineer Intern
Education:
New York University - New York, NY 2011 to 2012
Certificate in Application Development Columbia University - New York, NY 2006 to 2010
Bachelors of Science in Operations Research Engineering and Computer Science Columbia University - New York, NY 2013
Masters of Science in Computer Science

Publications & IP owners

Us Patents

Angiotensin Ii Receptor Antagonists

US Patent:
7834042, Nov 16, 2010
Filed:
Dec 11, 2007
Appl. No.:
12/312225
Inventors:
Iyassu K. Sebhat - Jersey City NJ, US
Michael Man-chu Lo - Edison NJ, US
Ravi P. Nargund - East Brunswick NJ, US
Amjad Ali - Freehold NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/41
C07D 257/04
US Classification:
514381, 548250
Abstract:
A compound having the structure (Formula I), wherein Y is —Y—Y—Y—Y—Y—; Yis C(O) or C(RR); Yis O, C(O), P(O)(OH) or CH, provided that when Yis C(O), Yis not C(O); Ris selected from the group consisting of hydrogen and Calkyl; Ris selected from the pup consisting of hydrogen, Calkyl, and —OC(O)Calkyl; Yis O, C(O) or CH, provided that when Yis C(O), then Yis not C(O), and further provided that when Yis O, then Yis not O; Yis O or CHor is absent, provided that when Yis O, then Yis not O; Y5 is —(CH)—(X)—(CH)— or is absent; X is —O— or —CRR—; and Rand Rare independently selected from the group consisting of hydrogen and C-Calkyl; or a pharmaceutically acceptable salt thereof, which is useful for treating hypertension.

Angiotensin Ii Receptor Antagonists

US Patent:
7880014, Feb 1, 2011
Filed:
Dec 11, 2007
Appl. No.:
12/000247
Inventors:
Iyassu K. Sebhat - Jersey City NJ, US
Michael Man-chu Lo - Edison NJ, US
Ravi P. Nargund - East Brunswick NJ, US
Amjad Ali - Freehold NJ, US
Chris Franklin - Keasbey NJ, US
Nicoletta Almirante - Milan, IT
Laura Storoni - Cesano Maderno, IT
Silvia Stefanini - San Donato Milanese, IT
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
NiCox S.A. - Valbonne
International Classification:
C07D 257/00
C07D 403/00
US Classification:
548250, 5483001
Abstract:
A compound having the structure.

Angiotensin Ii Receptor Antagonists

US Patent:
8293777, Oct 23, 2012
Filed:
Dec 2, 2009
Appl. No.:
12/629419
Inventors:
Michael Man-Chu Lo - Edison NJ, US
Amjad Ali - Freehold NJ, US
Ravi P. Nargund - East Brunswick NJ, US
Assignee:
Merck Sharp & Dohme, Corp. - Rahway NJ
International Classification:
A61K 31/34
A61K 31/41
C07D 249/00
C07D 409/02
US Classification:
514383, 514469, 548253, 5483064, 5483111
Abstract:
A compound having the structure.

Substituted Imidazoles As Bombesin Receptor Subtype-3 Modulators

US Patent:
8318767, Nov 27, 2012
Filed:
Dec 15, 2011
Appl. No.:
13/327093
Inventors:
David Chen - Singapore, SG
Christopher L. Franklin - Keasbey NJ, US
Peter R. Guzzo - Niskayuna NY, US
Linus S. Lin - Westfield NJ, US
Jian Liu - Edison NJ, US
Michael M.-C. Lo - Edison NJ, US
Ravi P. Nargund - East Brunswick NJ, US
Iyassu K. Sebhat - Jersey City NJ, US
Assignee:
Merck Sharp & Dohme Corp - Rahway NJ
Albany Molecular Research, Inc. - Albany NY
International Classification:
A61K 31/437
A61K 31/4439
A61K 31/427
A61K 31/4155
C07D 417/10
C07D 233/64
C07D 471/04
C07D 401/14
C07D 401/10
C07D 403/10
US Classification:
514303, 514397, 514400, 514372, 548214, 5483124, 5483411, 546119, 5462751
Abstract:
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.

Substituted Imidazoles As Bombesin Receptor Subtype-3 Modulators

US Patent:
2010000, Jan 7, 2010
Filed:
Oct 16, 2007
Appl. No.:
12/311541
Inventors:
David Chen - Singapore, SG
Christopher L. Franklin - Keasbey NJ, US
Peter R. Guzzo - Niskayuna NY, US
Linus S. Lin - Westfield NJ, US
Jian Liu - Edison NJ, US
Michael M.-C. Lo - Edison NJ, US
Ravi P. Nargund - East Brunswick NJ, US
Iyassu K. Sebhat - Jersey City NJ, US
International Classification:
A61K 31/437
C07D 401/10
C07D 231/02
C07D 471/04
A61K 31/44
A61K 31/4178
A61P 3/04
US Classification:
514303, 5462727, 5462751, 5483124, 546119, 514341, 514397
Abstract:
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.

Substituted Inmidazoles As Bombesin Receptor Subtype-3 Modulators

US Patent:
2010002, Jan 28, 2010
Filed:
Oct 16, 2007
Appl. No.:
12/311487
Inventors:
David Chen - Singapore, SG
Christopher L. Franklin - Keasbey NJ, US
Peter R. Guzzo - Niskayuna NJ, US
Linus S. Lin - Westfield NJ, US
Michael M.C. Lo - Edison NJ, US
Ravi P. Nargund - East Brunswick NJ, US
Iyassu K. Sebhat - Jersey City NJ, US
International Classification:
A61K 31/4178
C07D 403/10
A61P 3/04
A61P 3/10
C07D 401/10
A61K 31/4439
US Classification:
514341, 5483124, 514397, 5462751
Abstract:
Certain novel substituted imidazoles are ligands of the human bombesin receptor and, in particular, are selective ligands of the human bombesin receptor subtype-3 (BRS-3). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of BRS-3, such as obesity, and diabetes.

Angiotensin Ii Receptor Antagonists

US Patent:
2010015, Jun 17, 2010
Filed:
Dec 11, 2007
Appl. No.:
12/516482
Inventors:
Iyassu K. Sebhat - Jersey City NJ, US
Michael Man-chu Lo - Edison NJ, US
Ravi P. Nargund - East Brunswick NJ, US
Amjad Ali - Freehold NJ, US
Chris Franklin - Rahway NJ, US
Nicoletta Almirante - Milano, IT
Laura Storoni - Cesano Maderno, IT
Silvia Stefanini - San Donato Milanese, IT
Assignee:
Merck & Co Inc. - Rahway NJ
NICox S.A. - Valbonne
International Classification:
C07D 403/10
A61K 31/4184
A61P 9/12
US Classification:
514381, 514394, 548253, 5483054
Abstract:
A compound having the structure (Formula I), wherein R an angiotensin receptor antagonist active group, Y is Y—Y—Y—Y—Y. Yis C(RR); Ris selected from the group consisting of hydrogen and Calkyl; Ris selected from the group consisting of hydrogen, Calkyl, and -0C(0)Calkyl; Yis O or CH; Yis C(O) or CH; Yis O or CH; Y5 is —(CH2)—(X)—CH)— or is absent; X is —O— or —CRR—; and Rand Rare independently selected from the group consisting of hydrogen and C-Calkyl; or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.

Angiotensin Ii Receptor Blocker Derivatives

US Patent:
2011005, Mar 3, 2011
Filed:
Feb 19, 2009
Appl. No.:
12/866688
Inventors:
Nicoletta Almirante - Milano, IT
Alessia Nicotra - Grandate (Como), IT
Valentino Mandelli - Monza (Milano), IT
Stefano Biondi - Pero (Milano), IT
Silvia Stefanini - San Donato Milanese (Milano), IT
Iyassu K. Sebhat - Jersey City NJ, US
Michael Man-Chu Lo - Edison NJ, US
Assignee:
MERCK SHARP & DOHME CORP. - Rahway NJ
NICOX S.A. - Sophia Antipolis - Valbonne
International Classification:
A61K 9/127
C07D 403/10
A61K 31/41
C07D 403/14
C07D 471/04
A61K 31/519
C07D 257/04
A61K 31/4184
C07D 409/06
A61K 31/4178
A61K 9/12
A61K 9/28
A61K 9/48
A61P 9/00
A61P 13/12
A61P 27/06
A61P 25/00
US Classification:
424450, 548253, 514381, 544279, 5142641, 5483054, 514394, 5483151, 514397, 424 45, 424474, 424463
Abstract:
New angiotensin II receptor blocker nitroderivatives of general formula (I) and pharmaceutically acceptable salts or stereoisomers thereof: and their use for treating cardiovascular, renal and chronic liver diseases, inflammatory processes and metabolic syndromes.

Possible Relatives

David Y Lo  Aaron C Lo  Denise A Lo  Danny S Lo  Derrick Lo  Diane Lo  Donald H Lo  Michael C Last  Michael C Johnson  Michael F Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.